Regulatory pressures are at the top of the list of supply chain concerns voiced by pharmaceutical manufacturers in an annual UPS poll. Among respondents with more than $1 billion in sales, an increased regulatory burden was the top concern of 56 percent, while this factor topped the list for a third of smaller drugmakers. Report